Dipankar Gupta

CLIN ASO PROF

MD-PEDIATRICS

  • CLIN ASO PROF
    MD-PEDIATRICS

GRANTS

  • GRANT
    A multicenter, randomized, double-blind, placebo-controlled, Phase 3 study to investigate the efficacy, safety, and PK/ PD of finerenone, in addition to standard-of-care, in pediatric patients, 6 months to < 18 years of age, with left ventricular systolic dysfunction (LVSD)
    Bayer Healthcare Pharmaceuticals22 Jun 2026 - 21 Jun 2031
    Active
  • GRANT
    A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)
    Bayer Healthcare Pharmaceuticals22 Jun 2026 - 21 Jun 2031
    Active
  • GRANT
    Early Feasibility Data Collection Study Using ClearSight on Children Less than Twelve Years Old
    Edwards Lifesciences21 Nov 2024 - 20 Nov 2029
    Active
  • GRANT
    Elucidating the innate and adaptive immune mechanism differences during viral myocarditis between pediatric and adult populations: role of sex, age and hormone status
    National Institute of Health Niaid18 Jul 2024 - 31 May 2027
    Active
  • GRANT
    Pediatric HemOdynamic MonitorinG TechnOlogy2-cohort Study
    Edwards Lifesciences26 Apr 2024 - 25 Apr 2029
    Active
  • GRANT
    Fontan Udenafil Exercise Longitudinal Assessment Trial (the FUEL-2 Study)
    Mezzion29 Feb 2024 - 15 Feb 2029
    Active
  • GRANT
    CTOA
    University of Florida14 Dec 2023 - 13 Dec 2028
    Active
  • GRANT
    Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) Intervention for medication adherence in pediatric heart transplant patients
    National Institute of Health Nhlbi8 Dec 2023 - 31 Mar 2027
    Active
  • GRANT
    Prediction of Health Outcomes and Adverse Events in Pediatric Organ Transplantation in Florida.
    National Institute of Health Nlm31 Aug 2022 - 31 Jan 2025
    Expired
  • GRANT
    An open-label randomized, parallel group,multicenter observational trial to evaluate safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac diseases at risk of thromboembolic events.
    Daiichi Sankyo5 Nov 2019 - 21 Nov 2022
    Closed
  • GRANT
    Parental Decision Making in the Pediatric Cardiac Intensive Care Unit: a Cross-Sectional Study Addressing Parental Preferences and Associated Characteristics
    3 Sep 2019 - 31 May 2021
    Expired